Cotadutide, but not liraglutide improved hepatic parameters and metabolic dysfunction-associated steatohepatitis (MASH) with similar weight loss with 200 g cotadutide compared to 1.8 mg liraglutide and greater with 300 g cotadutide versus 1.8 mg liraglutide [47]
Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder [published correction appears in Eur J Clin Pharmacol
Adverse events across doses Adverse events reported in 5% of participants through 36 weeks Select Important Safety Information: Most common adverse reactions - Incidence reported in 5% of Trulicity-treated patients in trials were nausea, diarrhea, vomiting, abdominal pain, decreased appetite, dyspepsia, and fatigue
Graphical Abstract The effects of GLP-1 agonists on weight loss in patients with inflammatory bowel disease were examined
This absorption in the stomach and large intestine is almost negligible (Graham et al., 2011)
Choosing the best weight loss medication involves evaluating individual health needs, potential side effects, and desired outcomes